scholarly journals Characteristics of Serrated Adenomas in Non-Hispanic Whites and African Americans Undergoing Screening Colonoscopy

Cureus ◽  
2021 ◽  
Author(s):  
Lauren Stemboroski ◽  
Joshua Samuel ◽  
Ahmad Alkaddour ◽  
Nicholas Agresti ◽  
Ena Gupta ◽  
...  
2015 ◽  
Vol 110 ◽  
pp. S585
Author(s):  
Kenneth J. Vega ◽  
Joshua Samuel ◽  
Ena Gupta ◽  
Lauren Stemboroski ◽  
Ahmad AlKaddour ◽  
...  

2019 ◽  
Vol 114 (1) ◽  
pp. S140-S140
Author(s):  
Birmaji Ali ◽  
Peter Fahim ◽  
Jenni Steinbrunner ◽  
Robert Kindel

2000 ◽  
Vol 51 (5) ◽  
pp. 0524-0527 ◽  
Author(s):  
Amnon M. Sonnenberg ◽  
Douglas K. Rex ◽  
Abdul M. Khan ◽  
Prince M. Shah ◽  
Jeanette M. Newton

2015 ◽  
Vol 2015 ◽  
pp. 1-6
Author(s):  
Carlos Augusto Real Martinez ◽  
Júlia Cutovoi ◽  
Debora Helena Rossi ◽  
Luciana Rodrigues Meirelles ◽  
Maria de Lourdes Setsuko Ayrizono ◽  
...  

Introduction. Serrated adenomas of the appendix are rare and usually found during appendectomy or autopsies. The preoperative diagnosis of these tumors is uncommon. This report describes a case of a sessile serrated adenoma located in the appendix diagnosed by a screening colonoscopy and successfully treated by laparoscopic removal.Presentation of Case. An 86-year-old woman underwent colonoscopy to investigate the cause of her diarrhea, weight loss, and anemia. During the colonoscopy, an expansive and vegetating mass of 1.5 cm in diameter was identified, protruding through the appendicular ostium with slightly lateral growth to the cecum. The patient was referred for laparoscopic surgical resection due to the location of the lesion, which did not allow its removal by colonoscopy. She underwent wedge removal of the cecum without complications and was discharged on the 4th postoperative day. Histopathological examination showed the presence of a sessile serrated adenoma with an intramucosal adenocarcinoma. The patient is currently well one year after surgery, without endoscopic signs of relapse.Conclusion. Despite serrated adenomas being a possibility rarely described in appendix it should be recognized and properly treated because it is presenting a higher risk of cancer.


2021 ◽  
Author(s):  
Yan Gong ◽  
Yansong Zheng ◽  
Rilige Wu ◽  
Miao Liu ◽  
Hong Li ◽  
...  

Abstract Background: Screening colonoscopy has historically been recommended starting at the age of 50. However, the recommended age for beginning screening has recently been reduced to 45 independent of sex. However, studies on screening colonoscopies of average-risk individuals in China are sparse. This study aimed to determine and compare the prevalence of adenomas, advanced adenomas (AAs), and colorectal cancers (CRCs) and the number of individuals needing screening in an average-risk Chinese population of different ages and sexes.Methods: A total of 53,152 individuals undergoing colonoscopy were included from January 2013 to December 2019. We analysed and compared the prevalence of adenomas, AAs, and CRCs and the number of individuals needing screening in different age groups of men and women.Results: The average age of males was 48.80 years (SD, 8.47 years), that of females was 50.00 years (SD, 9.00 years), and the sex ratio was 66.28% (n=35,226) vs. 33.72% (n=17,926). The prevalence of adenomas, AAs, serrated adenomas and CRCs was 14.51% ([95% CI 14.21–14.81], n=7713), 3.04% ([95% CI 2.90–3.19], n=1617), 1.23% ([95% CI 1.01–1.32], n=653) and 0.59% ([95% CI 0.52–0.65], n=313), respectively. Male sex was significantly associated with a high prevalence of adenomas (17.14% [95% CI 16.74–17.53] vs 9.36% [95% CI 8.94–9.79], P<0.001), AAs (3.67% [95% CI 3.47–3.87] vs 1.81% [95% CI 1.61–2.00], P<0.001) and serrated adenomas (1.56% [95% CI 1.43–1.69] vs. 0.59% [95% CI 0.47–0.70], P<0.001). The prevalence of AAs in 45- to 49-year-old individuals was 3.17% (95% CI 2.80–3.55) in men and 1.49% (95% CI 1.12–1.86) in women. The number of men needing screening(NNS) was 31.55 (95% CI 28.17–35.71), while the number of women was 67.11 (95% CI 53.76–89.29). The prevalence and number of patients needing screening for AAs in men aged 45–49 years were close to those in women aged 65–69 years (31.55 [95% CI, 28.17–35.71] vs. 29.07 [95% CI, 21.05–46.73]).Conclusions: The prevalence of adenomas, AAs, and serrated adenomas increased with age. Males had a higher prevalence rate than females. The prevalence and NNS of AAs in 45- to 49-year-old men were close to those in 65- to 69-year-old women.


2011 ◽  
Vol 140 (5) ◽  
pp. S-20-S-21
Author(s):  
Gokulakrishnan Balasubramanian ◽  
Sundeep Shenoy ◽  
Vishnu Naravadi ◽  
Sreedhar reddy Madireddy ◽  
Arun K. Verma ◽  
...  

2019 ◽  
Vol 10 (2) ◽  
pp. 375-383
Author(s):  
Sarah J Miller ◽  
Jamilia R Sly ◽  
Kemi B Gaffney ◽  
Zhiye Jiang ◽  
Brittney Henry ◽  
...  

Abstract Compared with other racial/ethnic groups, African Americans have the highest colorectal cancer (CRC) morbidity and mortality rates. It is critical to help improve African Americans’ CRC prevention efforts in order to reduce the burden of CRC in this community. The aim of this study was to develop and field test a tablet app, called e-Motivate, designed to improve African Americans’ screening colonoscopy rates. The e-Motivate app was field tested, using an iterative approach. The first version of the app, e-Motivate 1.0, was field tested on 20 African Americans over the age of 50. Participants engaged in a think aloud exercise and provided feedback regarding the app’s usability and acceptability. The results of the first field test were used to modify the app and develop e-Motivate 2.0. The field test procedures were repeated on a new group of participants (N = 18). The results from the second field test were used to make final modifications to the app. Overall, participants responded positively to the app. Qualitative analyses showed that participants found the app to be easy to use and helpful. Furthermore, descriptive statistics revealed that participants found the app to be highly usable and acceptable, exceeding recommended benchmarks for usability and acceptability. Critiques of the app were used to modify and finalize the intervention. The results from the proposed study suggest that the e-Motivate app is highly feasible and acceptable. The next step in this line of research is to conduct a randomized clinical trial to formally test the efficacy of the e-Motivate app for improving screening colonoscopy rates among African Americans.


2013 ◽  
Vol 22 (9) ◽  
pp. 1577-1587 ◽  
Author(s):  
Lina Jandorf ◽  
Caitlyn Braschi ◽  
Elizabeth Ernstoff ◽  
Carrie R. Wong ◽  
Linda Thelemaque ◽  
...  

2013 ◽  
Vol 28 (4) ◽  
pp. 722-728 ◽  
Author(s):  
Carrie R. Wong ◽  
Elana R. Bloomfield ◽  
Danielle M. Crookes ◽  
Lina Jandorf

Sign in / Sign up

Export Citation Format

Share Document